Suppr超能文献

超越恒定的质子相对生物效应:欧美质子治疗机构的临床与研究视角调查

Beyond a constant proton relative biological effectiveness: A survey of clinical and research perspectives among proton institutions in Europe and the United States.

作者信息

Ödén Jakob, Eriksson Kjell, Kaushik Suryakant, Traneus Erik

机构信息

Department of Research, RaySearch Laboratories AB, Stockholm, Sweden.

出版信息

J Appl Clin Med Phys. 2025 Jan;26(1):e14535. doi: 10.1002/acm2.14535. Epub 2024 Nov 3.

Abstract

PURPOSE

Although proton relative biological effectiveness (RBE) depends on factors like linear energy transfer (LET), tissue properties, dose, and biological endpoint, a constant RBE of 1.1 is recommended in clinical practice. This study surveys proton institutions to explore activities using functionalities beyond a constant proton RBE.

METHODS

Research versions of RayStation integrate functionalities considering variable proton RBE, LET, proton track-ends, and dirty dose. A survey of 19 institutions in Europe and the United States, with these functionalities available, investigated clinical adoption and research prospects using a 25-question online questionnaire.

RESULTS

Of the 16 institutions that responded (84% response rate), 13 were clinically active. These clinical institutions prescribe RBE = 1.1 but also employ planning strategies centered around special beam arrangements to address potentially enhanced RBE effects in serially structured organs at risk (OARs). Clinical plan evaluation encompassed beam angles/spot position (69%), dose-averaged LET (LET) (46%), and variable RBE distributions (38%). High ratings (discrete scale: 1-5) were reported for the research functionalities using linear LET-RBE models, LET, track-end frequency and dirty dose (averages: 4.0-4.8), while LQ-based phenomenological RBE models dependent on LET scored lower for optimization (average: 2.2) but congruent for evaluation (average: 4.1). The institutions preferred LET reported as LET (94%), computed in unit-density water (56%), for all protons (63%), and lean toward LET-based phenomenological RBE models for clinical use (> 50%).

CONCLUSIONS

Proton institutions recognize RBE variability but adhere to a constant RBE while actively mitigating potential enhancements, particularly in serially structured OARs. Research efforts focus on planning techniques that utilize functionalities beyond a constant RBE, emphasizing standardized LET and RBE calculations to facilitate their adoption in clinical practice and improve clinical data collection. LET calculated in unit-density water for all protons as input to adaptable phenomenological RBE models was the most suggested approach, aligning with predominant clinical LET and variable RBE reporting.

摘要

目的

尽管质子相对生物效应(RBE)取决于线性能量传递(LET)、组织特性、剂量和生物学终点等因素,但临床实践中推荐的恒定RBE值为1.1。本研究对质子治疗机构进行调查,以探索使用超出恒定质子RBE功能的活动。

方法

RayStation的研究版本集成了考虑可变质子RBE、LET、质子径迹末端和脏剂量的功能。对欧洲和美国19家具备这些功能的机构进行了一项调查,使用一份包含25个问题的在线问卷来研究临床应用和研究前景。

结果

在回复的16家机构中(回复率84%),13家机构有临床活动。这些临床机构规定RBE = 1.1,但也采用围绕特殊射束排列的计划策略,以应对串联结构的危险器官(OAR)中潜在增强的RBE效应。临床计划评估包括射束角度/光斑位置(69%)、剂量平均LET(LET)(46%)和可变RBE分布(38%)。对于使用线性LET - RBE模型、LET、径迹末端频率和脏剂量的研究功能,报告的评分较高(离散量表:1 - 5)(平均值:4.0 - 4.8),而依赖LET的基于LQ的唯象RBE模型在优化方面得分较低(平均值:2.2),但在评估方面得分相当(平均值:4.1)。这些机构更喜欢将LET报告为LET(94%),在单位密度水中计算(56%),针对所有质子(63%),并且在临床使用中倾向于基于LET的唯象RBE模型(> 50%)。

结论

质子治疗机构认识到RBE的变异性,但在积极减轻潜在增强效应的同时坚持恒定的RBE,特别是在串联结构的OAR中。研究工作集中在利用超出恒定RBE功能的计划技术上,强调标准化的LET和RBE计算,以促进其在临床实践中的应用并改善临床数据收集。将所有质子在单位密度水中计算的LET作为可适应的唯象RBE模型的输入是最受推荐的方法,这与主要的临床LET和可变RBE报告一致。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5e73/11712586/60fa3d2bf52d/ACM2-26-e14535-g003.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验